Novavax Inc
Change company Symbol lookup
Select an option...
NVAX Novavax Inc
BAC Bank of America Corp
PCRFY Panasonic Holdings Corp
CRTD Creatd Inc
MSM MSC Industrial Direct Co Inc
FGEN FibroGen Inc
SUI Sun Communities Inc
HROWL HARROW HEALTH 8 625 SNR NTS
COF-I Capital One Financial Corp
VRAY ViewRay Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).

Postmarket

Last Trade
Delayed
$11.09
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$11.09
Day's Change
-0.14 (-1.25%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
11.44
Day's Low
10.96
Volume
(Light)
Volume:
4,087,235

10-day average volume:
7,244,166
4,087,235
Historical quotes & splits

Upcoming Events

NVAX's fiscal year ends in December
There are no upcoming events for NVAX

Past Earnings

This page reports
non-GAAP earnings

GAAP vs. Non-GAAP Earnings

TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.

.
DateEvent descriptionEarnings per
share actual		Earnings
estimate range		Previous year's
actual
November 8, 2022Q3 2022 Earnings Release-$2.15-$0.81 to $3.76-$4.31
August 8, 2022Q2 2022 Earnings Release-$6.53$4.62 to $7.09-$4.75
May 9, 2022Q1 2022 Earnings Release$2.56$1.30 to $3.86-$3.05
February 28, 2022Q4 2021 Earnings Release-$11.18-$5.16 to $7.89--

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.

3rd Party Research Disclosure